Solta Medical, Inc. is a global leader in the medical aesthetics industry, providing innovative, safe and effective solutions for patients, each designed to enhance and expand our partner physicians’ medical practices. With over a decade at the forefront of the aesthetics industry, we’ve marked some important milestones. Take a look back at our company’s history by selecting a timeline item.
Select a timeline item below.
February, 2013 - Solta acquires privately-held Sound Surgical Technologies, adding complementary surgical and non-invasive product lines to Solta’s broad portfolio of leading aesthetic brands. Surgical body contouring products include the popular VASERlipo™ system, which uses ultrasound waves to selectively emulsify fatty tissue prior to extraction from the body. VASERsmooth™, PowerX®, VentX® and Origins round out the surgical brand offerings, while VASERshape™, a non-invasive approach to reduce cellulite, rounds out the array of aesthetic body treatments.
May, 2013 - Solta announces the Thermage® Total Tip 3.0, a highly effective treatment tip for face and neck as well as other body treatments that offers the earliest visible results in Thermage treatment history in addition to the consistent long-term results. Targeted, uniform, bulk heating allows dermatologists to treat patients effectively while maintaining patient comfort.
June, 2013 - Solta announces Isolaz® 2, the next generation acne therapy device. Isolaz 2 effectively targets the root causes of acne through a unique, clinically proven combination of vacuum extraction for deep pore purification, broadband light to destroy acne causing bacteria, and a profusion mode to enhance the delivery of topicals into the skin.
June, 2013 - Solta announces that it has received a new FDA 510(k) clearance of its Fraxel® DUAL 1550/1927 laser system for the treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots) and ephelides (freckles). The Fraxel DUAL system is an unsurpassed breakthrough skin resurfacing technology that renews skin and helps maintain skin's youthful glow despite a person's age or skin color, with minimal discomfort and downtime.
May 2012 - Solta Medical announced the availability of the Fraxel re:pair® SST Laser Platform in the United States. The updated platform addresses the major needs of aging and sun-damaged skin and offers physicians unmatched versatility and customization to treat a broad range of clinical indications. It also offers patients a fast, single-pass, single-treatment option providing impressive resurfacing results with more comfort and reduced healing time compared to a traditional Fraxel re:pair treatment.
August 2012 - Solta Medical announced an exclusive partnership with SkinCeuticals to deliver the first fractional laser treatment plus in-office and home use antioxidant skincare regimen. The partnership is the culmination of clinical research supported by Solta and SkinCeuticals exploring the beneficial effects of using Solta´s Clear + Brilliant® Laser System with its new handpiece named Perméa™ and SkinCeuticals widely popular C E Ferulic® antioxidant.
February, 2011 - Solta introduces Clear + Brilliant® which creates and defines an entirely new category of laser aesthetic treatments designed to attract younger patients looking to take control of their aging process. Clear + Brilliant provides a new option for physicians and skin care providers to address evolving consumer needs.
November, 2011 - Solta acquires Liposonix®, adding another innovative technology to Solta Medical’s portfolio of products. Liposonix and its High Intensity Focused Ultrasound (HIFU) technology represent a unique technology in the fat ablation market, and complement the technology of the Thermage and Fraxel product lines.
October 2010 – Solta acquires CLRS Technology Corporation, the developer, manufacturer and marketer of the CLARO personal care acne treatment device, giving Solta direct access to an already marketed and FDA cleared consumer medical device.
February 2010 – Solta acquires privately held Aesthera Corporation and its proprietary Isolaz product line for the treatment of acne conditions that impact an estimated forty–to–fifty million individuals in the U.S. annually.
January 2009 – new corporate name Solta Medical, Inc. introduced as an "umbrella" corporate identity over a house of aesthetic brands.
August 2010 - Solta Medical announced approval of its Thermage CPT™ system. In the fall of 2009, the company received U.S. FDA clearance to market and sell the Thermage CPT system and now in Canada. The system is now available in over 100 countries worldwide. The Thermage CPT system represents a significant advancement in radiofrequency technology for the treatment of wrinkles and demonstrates Solta Medical's deep commitment to deliver cutting edge, innovative products to the anti-aging market.
August 2009 - Solta Medical announced the Fraxel re:store® Dual system, providing superior results for large body areas during a single treatment. Prior to the non-ablative Fraxel re:store Dual system, laser skin resurfacing procedures were largely limited to the face. The Fraxel re:store Dual takes the industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of a Thulium laser in the aesthetics market, optimized for treatment of pigmentation and other superficial skin conditions.
December 2008 – Thermage® acquires Reliant Technologies, Inc., bringing together the Thermage product line and Reliant’s Fraxel line of proprietary fractional laser technology.
By 2008 ThermaCool had received a series of indications expanding treatment to all parts of the body: In 2008 - Temporary improvement in the appearance of cellulite. In 2007 - Non-invasive treatment of the upper/lower eyelids. In 2005 - Non-invasive treatment of wrinkles & rhytids (expanded to off-face indications). In 2004 - Non-invasive treatment of facial wrinkles & rhytids. In 2002: Non-invasive treatment of periorbital wrinkles & rhytids.
February 2007 – Thermage introduced the ThermaCool® NXT, its next generation system for non-invasive skin tightening and contouring. With improvements inside and out, the industry-leading ThermaCool system has been redesigned to save time, reduce procedure cost, simplify the treatment experience and improve clinician comfort. ThermaCool NXT allows physicians to perform more procedures in less time while providing more flexibility and greater ease of use than ever before.
November 2006 – Thermage, Inc. goes public in an initial public offering and begins trading on the NASDAQ Global Market.
Thermage®, an innovative, non-invasive radiofrequency (RF) procedure for the non-invasive treatment of wrinkles. Thermage was the first aesthetic energy device company to successfully employ a recurring revenue model from disposable treatment tips.
ThermaCool receives initial indication for dermatologic and general surgical procedures for electrocoagulation and hemostasis.
The Company incorporates as Thermage, Inc. and begins research and development of the ThermaCool device.